Michael Schweizer, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Sanofi
    Topic: 
    Prostate cancer
    Date added: 
    02/08/2023
    Relationship end date: 
    02/16/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    AstraZeneca
    Topic: 
    Prostate cancer
    Date added: 
    02/08/2023
    Relationship end date: 
    08/11/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Pharmain
    Topic: 
    Prostate cancer
    Date added: 
    02/08/2023
    Relationship end date: 
    03/01/2022
Return to 2023 Summit on Cancer Health Disparities: Reframing and Addressing Barriers to Adoption of Precision Oncology